LULU vs MRNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 06, 2026

LULU

43.9
AI Score
VS
MRNA Wins

MRNA

48.8
AI Score

Investment Advisor Scores

LULU

44score
Recommendation
HOLD

MRNA

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LULU MRNA Winner
Revenue 2.47B 534.00M LULU
Net Income 195.05M -2.13B LULU
Net Margin 7.9% -397.9% LULU
Operating Income 276.95M -2.20B LULU
ROE 4.0% -31.4% LULU
ROA 2.3% -19.4% LULU
Total Assets 8.53B 10.96B MRNA
Current Ratio 2.23 2.29 MRNA
Free Cash Flow 87.06M -1.25B LULU

Relative Price Performance (Last 90 Days)

LULU 1M: +10.4% · 3M: -3.8% MRNA 1M: -22.7% · 3M: +21.9%

Current Technical Phase

LULU

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 66.3 · Price: $128.58

MRNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.2 · Price: $59.17

Fundamentals Snapshot

Metric LULU MRNA
Market Cap
Forward P/E 9.9 -11.0
Trailing P/E 10.0
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.6% -0.7%
Operating Margin 0.1% -5.6%
EPS 12.40 -7.88
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MRNA is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.